Trouble with balance and holding objects above one's head were just a few of the problems reported by patients 3 years before they received a formal Parkinson disease diagnosis, according to a recent study.
In recent years, more attention has been paid to the prodromal signs of Parkinson disease (PD)—that is, the signs and symptoms that appear years before a diagnosis is made. A recent case-control study, published in JAMA Neurology, indicated that individuals who have prodromal or unrecognized PD may have motor symptoms up to 3 years before diagnosis.
Researchers used Medicare-linked data from the National Health and Aging Trends Study (NHATS), a longitudinal, annual survey for a random subsample of Medicare beneficiaries 65 years or older. The sample was first interviewed in 2011 and then again in 2015, with response rates of 71% and 76%, respectively. Black participants and individuals 85 years or older were oversampled by design.
Patients with incident PD were defined as having 2 or more Medicare diagnoses from January 2011 to December 2017 and they had been eligible for Medicare 2 or more consecutive years prior to the first diagnosis. Controls without a PD diagnosis, with the same Medicare eligibility requirements, were also included.
Using logistic regression analysis, researchers sought to determine associations between survey responses and PD diagnosis in the first year of diagnosis and up to 3 years prior—in other words, during the prodromal phase. Analyses were conducted from November 2021 to June 2022.
Each year, participant numbers and case prevalence each year varied from 3492 to 5049 and from 700 to 1180 per 100,000 population, respectively. A total of 6674 participants were included in the analysis.
Fifty-six PD cases were identified and compared with 3466 controls.
The research identified 4 motor function issues that appeared 3 years before a formal PD diagnosis, with individuals indicating they were:
The authors said their findings, which are in line with other research, support the idea that the prodromal phase of PD "should be recognized as a disease stage in its own right, for which identification will be important for disease-modifying intervention." However, they also said it is possible that the findings indicate that some cases of PD are unrecoognized.
Reference
Miller-Patterson C, Hsu JY, Willis AW, et al. Functional impairment in individuals with prodromal or unrecognized Parkinson disease. JAMA Neurol. Published online December 19, 2022. doi:10.1001/jamaneurol.2022.4621
Valproate Exhibits Both Hypnotic, Antiepileptic Properties During Sleep
In an animal study, researchers found that valproate, a common epilepsy drug, possessed hypnotic and antiepileptic properties during sleep, suggesting that the drug could help improve sleep quality for patients with nocturnal epilepsy.
Read More
High-Deductible Health Plans and Their Potential Impact on the US Drug Epidemic
On this episode of Managed Care Cast, we speak with Matthew D. Eisenberg, PhD, lead author of a study published in the October issue of The American Journal of Managed Care® that investigated the use of high-deductible health plans and their impact on substance use disorder care and spending.
Listen
Study Finds Ixazomib Beneficial in MM Patients With High-Risk Cytogenic Traits
A recent study found that ixazomib was associated with better progression-free survival versus a placebo in multiple myeloma regardless of cytogenetic risk status.
Read More
The Importance of Tailored Care Management Programs for High-risk Patients
On this episode of Managed Care Cast, we speak with 2 authors of an article in the September issue of The American Journal of Managed Care®, which focused on the results of their evaluation of an intensive, community-based care management program for dual-eligible Medicaid ACO high-risk patients.
Listen
Rates of Depression, Anxiety Higher in MG Than in Other Autoimmune Diseases
The systemic review and meta-analysis, believe the researchers, is the first of its kind to characterize the prevalence of depression among these patients.
Read More
Diabetes Outcomes Better for Patients Enrolled in MA Than FFS Medicare
A new study highlighted that patients with diabetes enrolled in Medicare Advantage (MA) had better outcomes compared with patients in traditional fee-for-service (FFS) Medicare.
Read More
2 Clarke Drive
Cranbury, NJ 08512
609-716-7777